Valiant Laboratories Limited — Others, 11-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Valiant Laboratories has announced a board meeting to consider the financial results for the quarter and half-year. The company’s registrar and share transfer agent, MUFG Intime India, confirmed that all securities are held in dematerialized form, with no requests for dematerialization, mutilation, or cancellation received during the quarter. This indicates smooth shareholding management and no pending share-related actions, supporting operational stability and investor confidence.